ArticleJournal of applied clinical medical physics2025
Decision-making between DCA and VMAT in Linac-based SRS for brain lesions: A dosimetric analysis based on tumor size and geometry and introduction of Qasym.
Article in Journal of applied clinical medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Decision-making between DCA and VMAT in Linac-based SRS for brain lesions: A dosimetric analysis based on tumor size and geometry and introduction of Qasym.Journal of applied clinical medical physics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionLinac-based SRS provides a highly precise noninvasive treatment option for intracranial lesions. DCA and VMAT are commonly used Linac-based techniques. There are no standardized guidelines for technique selection, particularly considering the geometric properties of the lesions. We thus sought to compare DCA and VMAT to define a workflow for clinical decision-making. This study introduces Q MATERIALS AND
methodsBetween 2018 and 2021, a total of 89 brain metastases from 24 patients with lesion volumes up to 4.3 cm
resultsVMAT resulted in lower CI values, especially for volumes exceeding 2 cm
conclusionThis study provides detailed dosimetric information on two commonly applied planning techniques for Linac-based SRS treatment for brain metastases. These findings might support decision making for optimal technique selection upon volumetric features. Q
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.